DavidNielsenKragMD
General Surgery • Burlington, VTSurgical Oncology (Other than Breast)
Associate Professor of Surgery, University VT College of Medicine
Dr. Krag is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
111 Colchester Ave
Main Paviliionlevel 2
Burlington, VT 05401Phone+1 802-656-5830Fax+1 802-656-5833
Education & Training
University of California Davis HealthResidency, Surgery, 1982 - 1986
Yale-New Haven Medical CenterResidency, Surgery, 1980 - 1982
Loyola University Chicago Stritch School of MedicineClass of 1980
Certifications & Licensure
CA State Medical License 1982 - Present
VT State Medical License 1991 - 2026
FL State Medical License 2017 - 2019- American Board of Surgery Surgery
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2003-2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Join now to see all
Publications & Presentations
PubMed
- 8 citationsNovel β-lactamase-random peptide fusion libraries for phage display selection of cancer cell-targeting agents suitable for enzyme prodrug therapyGirja S. Shukla, David N. Krag
Journal of Drug Targeting. 2009-09-14 - 3 citationsPhage-displayed combinatorial peptide libraries in fusion to beta-lactamase as reporter for an accelerated clone screening: Potential uses of selected enzyme-linked af...Girja S. Shukla, David N. Krag
Combinatorial Chemistry & High Throughput Screening. 2010-01-01 - 10 citationsCancer cell-specific internalizing ligands from phage displayed β-lactamase-peptide fusion librariesGirja S. Shukla, David N. Krag
Protein Engineering, Design & Selection. 2010-06-01
Press Mentions
Tuesday CoronaBuzz, May 5, 2020: 30 Pointers to New Resources, Useful Stuff, Research News, and MoreMay 4th, 2020
Grant Support
- Sentinel Node Versus Axillary Dissection In Breast CancerNational Cancer Institute2007–2011
- Detection Of Micrometastatic Cancer Cells In Blood &Bone Marrow - Breast CancerNational Center For Research Resources2007
- Detection Of RARE Disseminated Tumor Cells In Blood And Bone MarrowNational Center For Research Resources2006–2007
- Serial Evaluation Of Serum Protein Profile Following Breast Cancer TreatmentNational Center For Research Resources2005–2007
- Targeted Enzymes For Prodrug TherapyNational Cancer Institute2005–2007
- In Vivo Selection Of Ligands For Targeted TherapyNational Center For Research Resources2004–2007
- Sentinel Node Versus Axillary Dissection In Breast CA.National Cancer Institute2005–2006
- Detection Of Micrometastatic Cancer Cells In Blood/Bone Marrow -Breast CancerNational Center For Research Resources2004–2006
- Detection Of Cancer Cells Added To Blood Samples Taken From Healthy IndividualsNational Center For Research Resources2004–2006
- Adjuvant Alfa-2b For Melanoma Patients With Early Lymph Node MetastasisNational Center For Research Resources2004–2006
- Targeting Breast Cancer With Small LigandsNational Cancer Institute1999–2006
- In Vivo Selection Of Ligands For Targeted TherapyNational Cancer Institute2002–2003
- Sentinel Node Versus Axillary Dissection--Breast CancerNational Cancer Institute2001–2003
- Adjuvant Interferon Alfa 2B For Melanoma PTS W/ Early Lymph Node MetastasesNational Center For Research Resources1999–2002
- Identification Of Small Peptides Which Target Cancer CELNational Cancer Institute2000–2001
- Sentinel Node In Breast Conserving TherapyNational Cancer Institute1998–2000
- Minimal Access Surgery For Staging Breast CancerNational Cancer Institute1994–1997
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
